tm logo
KYNVITAR
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 20 Dec 2024

Last Applicant/ Owned by

CH-4002

Basel

CH

4002

Serial Number

98074674 filed on 07th Jul 2023

Registration Number

N/A

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III TEPPER & EYSTER, PLLC

RALEIGH, NC 27609

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

KYNVITAR

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and Read More

Classification Information


Class [005]
Pharmaceutical Products


Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above excluding pharmaceutical preparations for the treatment of adenosine deaminase deficiency called SCID-ADA


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98074674

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Dec 2024SOU EXTENSION 1 GRANTED
20th Dec 2024SOU EXTENSION 1 FILED
20th Dec 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20th Dec 2024SOU TEAS EXTENSION RECEIVED
25th Jun 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30th Apr 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30th Apr 2024PUBLISHED FOR OPPOSITION
10th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26th Mar 2024APPROVED FOR PUB - PRINCIPAL REGISTER
15th Mar 2024ASSIGNED TO EXAMINER